SAN DIEGO, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp® ...

Next-generation sequencing (NGS) has transformed the medical and biological sciences, providing improved throughput and affordability. The cost of whole-genome sequencing has reduced considerably, ...

Automated library preparation is critical for reducing errors, increasing repeatability, and reducing hands-on time, allowing researchers to generate sequence data from DNA more quickly. The CyBio ...

BEVERLY, Mass.--(BUSINESS WIRE)--seqWell, a global provider of genomic library and multiplexing workflow solutions, today announced the early access availability of the new MosaiX™ Library Prep Kit, ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...

SAN DIEGO, May 18, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the first commercial shipment of its ...

Cell-free DNA (cfDNA) library preparation is fundamental for successful and efficient next-generation sequencing (NGS) workflows. Researchers apply these techniques to a wide range of platforms, ...

Although next-generation sequencing (NGS) keeps giving—exploring the human genome and revolutionizing our knowledge of health and disease—it needs to take a little, too. At the very least, NGS ...

In today’s rapidly evolving landscape of next-generation sequencing (NGS), researchers face mounting pressure to deliver high-quality data from increasingly diverse and challenging sample types. From ...

Our staff has over 30 years of combined experience with different RNA library prep kits, from high quality samples to FFPE. We provide free consultations to all users before submitting a project to ...

SOUTH SAN FRANCISCO, Calif., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive ...